{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T11:33:01Z","timestamp":1782991981187,"version":"3.54.5"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T00:00:00Z","timestamp":1774742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T00:00:00Z","timestamp":1774742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81970357"],"award-info":[{"award-number":["81970357"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82270434"],"award-info":[{"award-number":["82270434"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Key R&D Project of Liaoning Provincial Department of Science and Technology","award":["2025JH2\/101300019"],"award-info":[{"award-number":["2025JH2\/101300019"]}]},{"name":"Key R&D Project of Liaoning Provincial Department of Science and Technology","award":["2024JH2\/102500033"],"award-info":[{"award-number":["2024JH2\/102500033"]}]},{"name":"the Research Project of Educational Commission of Liaoning Province","award":["LJ212410164003"],"award-info":[{"award-number":["LJ212410164003"]}]},{"name":"Liaoning Provincial Department of Education Research Platform Construction Project","award":["LJ232410164023"],"award-info":[{"award-number":["LJ232410164023"]}]},{"name":"Shenyang Science and Technology Bureau Public Health Research and Development Special Project","award":["24-214-3-145"],"award-info":[{"award-number":["24-214-3-145"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s12272-026-01610-3","type":"journal-article","created":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T08:19:43Z","timestamp":1774772383000},"page":"554-574","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tirzepatide mitigates atherosclerosis progression and modulates oxLDL-mediated proatherogenic effects in macrophages: evidence for M1\/M2 homeostasis restoration"],"prefix":"10.1007","volume":"49","author":[{"given":"Mengjie","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HaoLin","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanru","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0269-8588","authenticated-orcid":false,"given":"Junjia","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2622-9327","authenticated-orcid":false,"given":"Yueyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9075-345X","authenticated-orcid":false,"given":"Ming-Sheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,29]]},"reference":[{"key":"1610_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mbs.2024.109208","author":"IU Ahmed","year":"2024","unstructured":"Ahmed IU, Myerscough MR (2024) HDL and plaque regression in a multiphase model of early atherosclerosis. Math Biosci. https:\/\/doi.org\/10.1016\/j.mbs.2024.109208","journal-title":"Math Biosci"},{"issue":"5","key":"1610_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11538-023-01142-7","volume":"85","author":"IU Ahmed","year":"2023","unstructured":"Ahmed IU, Byrne HM, Myerscough MR (2023) Macrophage anti-inflammatory behaviour in a multiphase model of atherosclerotic plaque development. Bull Math Biol 85(5):37. https:\/\/doi.org\/10.1007\/s11538-023-01142-7","journal-title":"Bull Math Biol"},{"issue":"7","key":"1610_CR3","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41569-019-0169-2","volume":"16","author":"M B\u00e4ck","year":"2019","unstructured":"B\u00e4ck M, Yurdagul A Jr., Tabas I, \u00d6\u00f6rni K, Kovanen PT (2019) Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities. Nat Rev Cardiol 16(7):389\u2013406. https:\/\/doi.org\/10.1038\/s41569-019-0169-2","journal-title":"Nat Rev Cardiol"},{"issue":"8","key":"1610_CR4","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1161\/circresaha.123.324086","volume":"134","author":"Q Bao","year":"2024","unstructured":"Bao Q, Zhang B, Zhou L, Yang Q, Mu X, Liu X, Zhang S, Yuan M, Zhang Y, Che J, Wei W, Liu T, Li G, He J (2024) CNP ameliorates macrophage inflammatory response and atherosclerosis. Circ Res 134(8):e72\u2013e91. https:\/\/doi.org\/10.1161\/circresaha.123.324086","journal-title":"Circ Res"},{"issue":"8","key":"1610_CR5","doi-asserted-by":"publisher","first-page":"108783","DOI":"10.1016\/j.jdiacomp.2024.108783","volume":"38","author":"A Bilal","year":"2024","unstructured":"Bilal A, Yi F, Gonzalez GR, Ali M, Im K, Ruff CT, Thethi TK, Pratley RE (2024) Effects of newer anti-hyperglycemic agents on cardiovascular outcomes in older adults: systematic review and meta-analysis. J Diabetes Complic 38(8):108783. https:\/\/doi.org\/10.1016\/j.jdiacomp.2024.108783","journal-title":"J Diabetes Complic"},{"issue":"2","key":"1610_CR6","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/fjc.0000000000001299","volume":"80","author":"J Bucheit","year":"2022","unstructured":"Bucheit J, Ayers J, Pamulapati L, Browning A, Sisson E (2022) A novel dual incretin agent, Tirzepatide (LY3298176), for the treatment of type 2 diabetes mellitus and cardiometabolic health. J Cardiovasc Pharmacol 80(2):171\u2013179. https:\/\/doi.org\/10.1097\/fjc.0000000000001299","journal-title":"J Cardiovasc Pharmacol"},{"issue":"7","key":"1610_CR7","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1161\/01.Cir.0000112585.47513.45","volume":"109","author":"MS Burnett","year":"2004","unstructured":"Burnett MS, Durrani S, Stabile E, Saji M, Lee CW, Kinnaird TD, Hoffman EP, Epstein SE (2004) Murine cytomegalovirus infection increases aortic expression of proatherosclerotic genes. Circulation 109(7):893\u2013897. https:\/\/doi.org\/10.1161\/01.Cir.0000112585.47513.45","journal-title":"Circulation"},{"key":"1610_CR8","doi-asserted-by":"publisher","DOI":"10.1172\/jci186509","author":"L Cao","year":"2025","unstructured":"Cao L, Zhang J, Yu L, Yang W, Qi W, Ren R, Liu Y, Hou Y, Cao Y, Li Q, Wang X, Zhang Z, Li B, Sui W, Zhang Y, Gao C, Zhang C, Zhang M (2025) E3 ubiquitin ligase Listerin regulates macrophage cholesterol efflux and atherosclerosis by targeting ABCA1. J Clin Invest. https:\/\/doi.org\/10.1172\/jci186509","journal-title":"J Clin Invest"},{"issue":"1","key":"1610_CR9","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12933-024-02181-7","volume":"23","author":"A Cersosimo","year":"2024","unstructured":"Cersosimo A, Salerno N, Sabatino J, Scatteia A, Bisaccia G, De Rosa S, Dellegrottaglie S, Bucciarelli-Ducci C, Torella D, Leo I (2024) Underlying mechanisms and cardioprotective effects of SGLT2i and GLP-1Ra: insights from cardiovascular magnetic resonance. Cardiovasc Diabetol 23(1):94. https:\/\/doi.org\/10.1186\/s12933-024-02181-7","journal-title":"Cardiovasc Diabetol"},{"key":"1610_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031882","author":"P Chandrasekaran","year":"2024","unstructured":"Chandrasekaran P, Weiskirchen R (2024) The role of obesity in type 2 diabetes mellitus-an overview. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25031882","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1610_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.intimp.2014.08.002","volume":"23","author":"W Chanput","year":"2014","unstructured":"Chanput W, Mes JJ, Wichers HJ (2014) THP-1 cell line: an in vitro cell model for immune modulation approach. Int Immunopharmacol 23(1):37\u201345. https:\/\/doi.org\/10.1016\/j.intimp.2014.08.002","journal-title":"Int Immunopharmacol"},{"key":"1610_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/nu16223873","author":"CA Chatzi","year":"2024","unstructured":"Chatzi CA, Basios A, Markozannes G, Ntzani EE, Tsilidis KK, Kazakos K, Agouridis AP, Barkas F, Pappa M, Katsiki N, Rizos EC (2024) Effect of different dietary patterns on cardiometabolic risk factors: an umbrella review of systematic reviews and meta-analyses. Nutrients. https:\/\/doi.org\/10.3390\/nu16223873","journal-title":"Nutrients"},{"issue":"9","key":"1610_CR13","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1210\/clinem\/dgae100","volume":"109","author":"GC Chen","year":"2024","unstructured":"Chen GC, Hukportie DN, Liu YJ, Wang HP, Qin LQ, Fan WD, Li FR, Wu XB (2024) Microvascular disease, cardiovascular health, and risk of coronary heart disease in type 2 diabetes: a UK Biobank study. J Clin Endocrinol Metab 109(9):2335\u20132342. https:\/\/doi.org\/10.1210\/clinem\/dgae100","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1610_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/fjc.0000000000000087","volume":"64","author":"Y Dai","year":"2014","unstructured":"Dai Y, Dai D, Wang X, Ding Z, Li C, Mehta JL (2014) GLP-1 agonists inhibit ox-LDL uptake in macrophages by activating protein kinase A. J Cardiovasc Pharmacol 64(1):47\u201352. https:\/\/doi.org\/10.1097\/fjc.0000000000000087","journal-title":"J Cardiovasc Pharmacol"},{"key":"1610_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2024.117560","author":"A Dardano","year":"2024","unstructured":"Dardano A, Bianchi C, Garofolo M, Del Prato S (2024) The current landscape for diabetes treatment: preventing diabetes-associated CV risk. Atherosclerosis. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.117560","journal-title":"Atherosclerosis"},{"issue":"10313","key":"1610_CR16","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/s0140-6736(21)02188-7","volume":"398","author":"S Del Prato","year":"2021","unstructured":"Del Prato S, Kahn SE, Pavo I, Weerakkody GJ, Yang Z, Doupis J, Aizenberg D, Wynne AG, Riesmeyer JS, Heine RJ, Wiese RJ (2021) Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial. Lancet 398(10313):1811\u20131824. https:\/\/doi.org\/10.1016\/s0140-6736(21)02188-7","journal-title":"Lancet"},{"issue":"49","key":"1610_CR17","doi-asserted-by":"publisher","first-page":"e202410237","DOI":"10.1002\/anie.202410237","volume":"63","author":"TC Dinsmore","year":"2024","unstructured":"Dinsmore TC, Liu J, Miao J, \u00dcnsal \u00d6, S\u00fcrmeli D, Beinborn M, Lin YS, Kumar K (2024) Potent and protease resistant azapeptide agonists of the GLP-1 and GIP receptors. Angew Chem Int Ed Engl 63(49):e202410237. https:\/\/doi.org\/10.1002\/anie.202410237","journal-title":"Angew Chem Int Ed Engl"},{"issue":"10402","key":"1610_CR18","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/s0140-6736(23)01200-x","volume":"402","author":"WT Garvey","year":"2023","unstructured":"Garvey WT, Frias JP, Jastreboff AM, Le Roux CW, Sattar N, Aizenberg D, Mao H, Zhang S, Ahmad NN, Bunck MC, Benabbad I, Zhang XM (2023) Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet 402(10402):613\u2013626. https:\/\/doi.org\/10.1016\/s0140-6736(23)01200-x","journal-title":"Lancet"},{"issue":"1","key":"1610_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/endrev\/bnae021","volume":"46","author":"I Gianopoulos","year":"2025","unstructured":"Gianopoulos I, Mantzoros CS, Daskalopoulou SS (2025) Adiponectin and adiponectin receptors in atherosclerosis. Endocr Rev 46(1):1\u201325. https:\/\/doi.org\/10.1210\/endrev\/bnae021","journal-title":"Endocr Rev"},{"key":"1610_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00178","author":"MP Gilbert","year":"2020","unstructured":"Gilbert MP, Pratley RE (2020) GLP-1 analogs and DPP-4 inhibitors in type 2 diabetes therapy: review of head-to-head clinical trials. Front Endocrinol. https:\/\/doi.org\/10.3389\/fendo.2020.00178","journal-title":"Front Endocrinol"},{"issue":"2","key":"1610_CR21","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00281-017-0656-7","volume":"40","author":"L Groh","year":"2018","unstructured":"Groh L, Keating ST, Joosten LA, Netea MG, Riksen NP (2018) Monocyte and macrophage immunometabolism in atherosclerosis. Semin Immunopathol 40(2):203\u2013214. https:\/\/doi.org\/10.1007\/s00281-017-0656-7","journal-title":"Semin Immunopathol"},{"key":"1610_CR22","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.174825","author":"R Hammoud","year":"2024","unstructured":"Hammoud R, Kaur KD, Koehler JA, Baggio LL, Wong CK, Advani KE, Yusta B, Efimova I, Gribble FM, Reimann F, Fishman S, Varol C, Drucker DJ (2024) Glucose-dependent insulinotropic polypeptide receptor signaling alleviates gut inflammation in mice. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.174825","journal-title":"JCI Insight"},{"issue":"1","key":"1610_CR23","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s10020-023-00685-8","volume":"29","author":"Z Han","year":"2023","unstructured":"Han Z, Hu H, Yin M, Lin Y, Yan Y, Han P, Liu B, Jing B (2023) HOXA1 participates in VSMC-to-macrophage-like cell transformation via regulation of NF-\u03baB p65 and KLF4: a potential mechanism of atherosclerosis pathogenesis. Mol Med 29(1):104. https:\/\/doi.org\/10.1186\/s10020-023-00685-8","journal-title":"Mol Med"},{"issue":"1","key":"1610_CR24","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/dom.15318","volume":"26","author":"ER Hankosky","year":"2024","unstructured":"Hankosky ER, Wang H, Neff LM, Kan H, Wang F, Ahmad NN, Griffin R, Stefanski A, Garvey WT (2024) Tirzepatide reduces the predicted risk of atherosclerotic cardiovascular disease and improves cardiometabolic risk factors in adults with obesity or overweight: SURMOUNT-1 post hoc analysis. Diabetes Obes Metab 26(1):319\u2013328. https:\/\/doi.org\/10.1111\/dom.15318","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"1610_CR25","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/s2213-8587(22)00085-7","volume":"10","author":"T Heise","year":"2022","unstructured":"Heise T, Mari A, Devries JH, Urva S, Li J, Pratt EJ, Coskun T, Thomas MK, Mather KJ, Haupt A, Milicevic Z (2022) Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial. Lancet Diabetes Endocrinol 10(6):418\u2013429. https:\/\/doi.org\/10.1016\/s2213-8587(22)00085-7","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"1610_CR26","doi-asserted-by":"publisher","first-page":"998","DOI":"10.2337\/dc22-1710","volume":"46","author":"T Heise","year":"2023","unstructured":"Heise T, Devries JH, Urva S, Li J, Pratt EJ, Thomas MK, Mather KJ, Karanikas CA, Dunn J, Haupt A, Milicevic Z, Coskun T (2023) Tirzepatide reduces appetite, energy intake, and fat mass in people with type 2 diabetes. Diabetes Care 46(5):998\u20131004. https:\/\/doi.org\/10.2337\/dc22-1710","journal-title":"Diabetes Care"},{"issue":"15","key":"1610_CR27","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.2174\/1389201022666210122142233","volume":"22","author":"D Hu","year":"2021","unstructured":"Hu D, Wang Z, Wang Y, Liang C (2021) Targeting macrophages in atherosclerosis. Curr Pharm Biotechnol 22(15):2008\u20132018. https:\/\/doi.org\/10.2174\/1389201022666210122142233","journal-title":"Curr Pharm Biotechnol"},{"key":"1610_CR28","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.97854","author":"Y Huang","year":"2024","unstructured":"Huang Y, Mo H, Yang J, Gao L, Tao T, Shu Q, Guo W, Zhao Y, Lyu J, Wang Q, Guo J, Zhai H, Zhu L, Chen H, Xu G (2024) Mechano-regulation of GLP-1 production by Piezo1 in intestinal L cells. Elife. https:\/\/doi.org\/10.7554\/eLife.97854","journal-title":"Elife"},{"issue":"12","key":"1610_CR29","doi-asserted-by":"publisher","first-page":"6011","DOI":"10.4049\/jimmunol.1402797","volume":"194","author":"N Kapoor","year":"2015","unstructured":"Kapoor N, Niu J, Saad Y, Kumar S, Sirakova T, Becerra E, Li X, Kolattukudy PE (2015) Transcription factors STAT6 and KLF4 implement macrophage polarization via the dual catalytic powers of MCPIP. J Immunol 194(12):6011\u20136023. https:\/\/doi.org\/10.4049\/jimmunol.1402797","journal-title":"J Immunol"},{"key":"1610_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24119737","author":"E Kassi","year":"2023","unstructured":"Kassi E, Kyrou I, Randeva HS (2023) Atherosclerotic and cardio-metabolic diseases: from molecular basis to therapeutic advances. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24119737","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1610_CR31","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3390\/medicina60030395","volume":"60","author":"K Katogiannis","year":"2024","unstructured":"Katogiannis K, Thymis J, Kousathana F, Pavlidis G, Korakas E, Kountouri A, Balampanis K, Prentza V, Kostelli G, Michalopoulou H, Tsilivarakis D, Lambadiari V, Ikonomidis I (2024) Effects of liraglutide, empagliflozin and their combination on left atrial strain and arterial function. Medicina 60(3):395. https:\/\/doi.org\/10.3390\/medicina60030395","journal-title":"Medicina"},{"issue":"11","key":"1610_CR32","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1093\/cvr\/cvae142","volume":"120","author":"TTJ Kufazvinei","year":"2024","unstructured":"Kufazvinei TTJ, Chai J, Boden KA, Channon KM, Choudhury RP (2024) Emerging opportunities to target inflammation: myocardial infarction and type 2 diabetes. Cardiovasc Res 120(11):1241\u20131252. https:\/\/doi.org\/10.1093\/cvr\/cvae142","journal-title":"Cardiovasc Res"},{"issue":"6","key":"1610_CR33","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.pcd.2024.09.007","volume":"18","author":"SK Kunutsor","year":"2024","unstructured":"Kunutsor SK, Seidu BS, Seidu S (2024) Cardiovascular effectiveness of newer glucose-lowering agents, with and without baseline lipid-lowering therapy in type 2 diabetes: a systematic meta-analysis of cardiovascular outcome trials and real-world evidence. Prim Care Diabetes 18(6):589\u2013598. https:\/\/doi.org\/10.1016\/j.pcd.2024.09.007","journal-title":"Prim Care Diabetes"},{"issue":"1","key":"1610_CR34","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1161\/cir.0000000000001145","volume":"148","author":"TW Kwan","year":"2023","unstructured":"Kwan TW, Wong SS, Hong Y, Kanaya AM, Khan SS, Hayman LL, Shah SH, Welty FK, Deedwania PC, Khaliq A, Palaniappan LP (2023) Epidemiology of diabetes and atherosclerotic cardiovascular disease among Asian American adults: implications, management, and future directions: a scientific statement from the American Heart Association. Circulation 148(1):74\u201394. https:\/\/doi.org\/10.1161\/cir.0000000000001145","journal-title":"Circulation"},{"key":"1610_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2024.111816","author":"NM Lali\u0107","year":"2024","unstructured":"Lali\u0107 NM, Joti\u0107 A, Luki\u0107 L, Mili\u010di\u0107 T, Ma\u0107e\u0161i\u0107 M, Stanar\u010di\u0107 Gajovi\u0107 J, Stoiljkovi\u0107 M, Milovan\u010devi\u0107 M, Rafailovi\u0107 Cvetkovi\u0107 D, Lali\u0107 K (2024) Glucose lowering drug or strategy dependent impact of weight reduction on the prevention of CVD outcomes in type 2 diabetes: a systematic review of CVOTs. Diabetes Res Clin Pract. https:\/\/doi.org\/10.1016\/j.diabres.2024.111816","journal-title":"Diabetes Res Clin Pract"},{"key":"1610_CR36","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.80944","author":"TDV Le","year":"2023","unstructured":"Le TDV, Liu D, Besing GK, Raghavan R, Ellis BJ, Ceddia RP, Collins S, Ayala JE (2023) Glucagon-like peptide-1 receptor activation stimulates PKA-mediated phosphorylation of Raptor and this contributes to the weight loss effect of liraglutide. Elife. https:\/\/doi.org\/10.7554\/eLife.80944","journal-title":"Elife"},{"issue":"7","key":"1610_CR37","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1172\/jci45444","volume":"121","author":"X Liao","year":"2011","unstructured":"Liao X, Sharma N, Kapadia F, Zhou G, Lu Y, Hong H, Paruchuri K, Mahabeleshwar GH, Dalmas E, Venteclef N, Flask CA, Kim J, Doreian BW, Lu KQ, Kaestner KH, Hamik A, Cl\u00e9ment K, Jain MK (2011) Kr\u00fcppel-like factor 4 regulates macrophage polarization. J Clin Invest 121(7):2736\u20132749. https:\/\/doi.org\/10.1172\/jci45444","journal-title":"J Clin Invest"},{"issue":"663","key":"1610_CR38","doi-asserted-by":"publisher","first-page":"eadd2376","DOI":"10.1126\/scitranslmed.add2376","volume":"14","author":"HP Lin","year":"2022","unstructured":"Lin HP, Singla B, Ahn W, Ghoshal P, Blahove M, Cherian-Shaw M, Chen A, Haller A, Hui DY, Dong K, Zhou J, White J, Stranahan AM, Jasztal A, Lucas R, Stansfield BK, Fulton D, Chlopicki S, Cs\u00e1nyi G (2022) Receptor-independent fluid-phase macropinocytosis promotes arterial foam cell formation and atherosclerosis. Sci Transl Med 14(663):eadd2376. https:\/\/doi.org\/10.1126\/scitranslmed.add2376","journal-title":"Sci Transl Med"},{"issue":"1","key":"1610_CR39","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12865-020-00355-y","volume":"21","author":"L Liu","year":"2020","unstructured":"Liu L, Guo H, Song A, Huang J, Zhang Y, Jin S, Li S, Zhang L, Yang C, Yang P (2020) Progranulin inhibits LPS-induced macrophage M1 polarization via NF-\u043aB and MAPK pathways. BMC Immunol 21(1):32. https:\/\/doi.org\/10.1186\/s12865-020-00355-y","journal-title":"BMC Immunol"},{"key":"1610_CR40","doi-asserted-by":"publisher","first-page":"1352946","DOI":"10.3389\/fimmu.2024.1352946","volume":"15","author":"M Luo","year":"2024","unstructured":"Luo M, Zhao F, Cheng H, Su M, Wang Y (2024) Macrophage polarization: an important role in inflammatory diseases. Front Immunol 15:1352946. https:\/\/doi.org\/10.3389\/fimmu.2024.1352946","journal-title":"Front Immunol"},{"issue":"8","key":"1610_CR41","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.7150\/ijbs.59965","volume":"17","author":"X Ma","year":"2021","unstructured":"Ma X, Liu Z, Ilyas I, Little PJ, Kamato D, Sahebka A, Chen Z, Luo S, Zheng X, Weng J, Xu S (2021) GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential. Int J Biol Sci 17(8):2050\u20132068. https:\/\/doi.org\/10.7150\/ijbs.59965","journal-title":"Int J Biol Sci"},{"key":"1610_CR42","doi-asserted-by":"publisher","first-page":"8563845","DOI":"10.1155\/2019\/8563845","volume":"2019","author":"P Marchio","year":"2019","unstructured":"Marchio P, Guerra-Ojeda S, Vila JM, Aldasoro M, Victor VM, Mauricio MD (2019) Targeting early atherosclerosis: a focus on oxidative stress and inflammation. Oxid Med Cell Longev 2019:8563845. https:\/\/doi.org\/10.1155\/2019\/8563845","journal-title":"Oxid Med Cell Longev"},{"issue":"12","key":"1610_CR43","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1210\/clinem\/dgae319","volume":"109","author":"KJ Mather","year":"2024","unstructured":"Mather KJ, Mari A, Heise T, Devries JH, Hua M, Urva S, Coskun T, Haupt A, Heine RJ, Pratt E, Thomas MK, Milicevic Z (2024) Effects of tirzepatide vs semaglutide on \u03b2-cell function, insulin sensitivity, and glucose control during a meal test. J Clin Endocrinol Metab 109(12):3046\u20133054. https:\/\/doi.org\/10.1210\/clinem\/dgae319","journal-title":"J Clin Endocrinol Metab"},{"issue":"22","key":"1610_CR44","doi-asserted-by":"publisher","first-page":"e153732","DOI":"10.1172\/jci.insight.153732","volume":"6","author":"BA Mclean","year":"2021","unstructured":"Mclean BA, Wong CK, Kaur KD, Seeley RJ, Drucker DJ (2021) Differential importance of endothelial and hematopoietic cell GLP-1Rs for cardiometabolic versus hepatic actions of semaglutide. JCI Insight 6(22):e153732. https:\/\/doi.org\/10.1172\/jci.insight.153732","journal-title":"JCI Insight"},{"key":"1610_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2023.09.007","author":"SJ Nicholls","year":"2024","unstructured":"Nicholls SJ, Bhatt DL, Buse JB, Prato SD, Kahn SE, Lincoff AM, Mcguire DK, Nauck MA, Nissen SE, Sattar N, Zinman B, Zoungas S, Basile J, Bartee A, Miller D, Nishiyama H, Pavo I, Weerakkody G, Wiese RJ, D\u2019alessio D (2024) Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS-CVOT design and baseline characteristics. Am Heart J. https:\/\/doi.org\/10.1016\/j.ahj.2023.09.007","journal-title":"Am Heart J"},{"issue":"1","key":"1610_CR46","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12933-018-0762-4","volume":"17","author":"V Ormazabal","year":"2018","unstructured":"Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zu\u00f1iga FA (2018) Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol 17(1):122. https:\/\/doi.org\/10.1186\/s12933-018-0762-4","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"1610_CR47","doi-asserted-by":"publisher","first-page":"146","DOI":"10.4093\/dmj.2020.0282","volume":"45","author":"JJ Park","year":"2021","unstructured":"Park JJ (2021) Epidemiology, pathophysiology, diagnosis and treatment of heart failure in diabetes. Diabetes Metab J 45(2):146\u2013157. https:\/\/doi.org\/10.4093\/dmj.2020.0282","journal-title":"Diabetes Metab J"},{"issue":"5","key":"1610_CR48","doi-asserted-by":"publisher","first-page":"H1159","DOI":"10.1152\/ajpheart.00574.2023","volume":"326","author":"B Park","year":"2024","unstructured":"Park B, Bakbak E, Teoh H, Krishnaraj A, Dennis F, Quan A, Rotstein OD, Butler J, Hess DA, Verma S (2024) GLP-1 receptor agonists and atherosclerosis protection: the vascular endothelium takes center stage. Am J Physiol Heart Circ Physiol 326(5):H1159-h1176. https:\/\/doi.org\/10.1152\/ajpheart.00574.2023","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"1610_CR49","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s40425-019-0697-7","volume":"7","author":"S Paul","year":"2019","unstructured":"Paul S, Chhatar S, Mishra A, Lal G (2019) Natural killer t cell activation increases iNOS+CD206\u2212 M1 macrophage and controls the growth of solid tumor. J Immunother Cancer 7(1):208. https:\/\/doi.org\/10.1186\/s40425-019-0697-7","journal-title":"J Immunother Cancer"},{"issue":"1","key":"1610_CR50","doi-asserted-by":"publisher","first-page":"112507","DOI":"10.1016\/j.yexcr.2021.112507","volume":"400","author":"Y Qiu","year":"2021","unstructured":"Qiu Y, Xu J, Yang L, Zhao G, Ding J, Chen Q, Zhang N, Yang R, Wang J, Li S, Zhang L (2021) MiR-375 silencing attenuates pro-inflammatory macrophage response and foam cell formation by targeting KLF4. Exp Cell Res 400(1):112507. https:\/\/doi.org\/10.1016\/j.yexcr.2021.112507","journal-title":"Exp Cell Res"},{"issue":"7","key":"1610_CR51","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/j.cmet.2024.05.010","volume":"36","author":"A Regmi","year":"2024","unstructured":"Regmi A, Aihara E, Christe ME, Varga G, Beyer TP, Ruan X, Beebe E, O\u2019Farrell LS, Bellinger MA, Austin AK, Lin Y, Hu H, Konkol DL, Wojnicki S, Holland AK, Friedrich JL, Brown RA, Estelle AS, Badger HS, Gaidosh GS, Kooijman S, Rensen PCN, Coskun T, Thomas MK, Roell W (2024) Tirzepatide modulates the regulation of adipocyte nutrient metabolism through long-acting activation of the GIP receptor. Cell Metab 36(7):1534\u20131549. https:\/\/doi.org\/10.1016\/j.cmet.2024.05.010","journal-title":"Cell Metab"},{"key":"1610_CR52","doi-asserted-by":"publisher","first-page":"175184","DOI":"10.1016\/j.ejphar.2022.175184","volume":"931","author":"Y Rui","year":"2022","unstructured":"Rui Y, Han X, Jiang A, Hu J, Li M, Liu B, Qian F, Huang L (2022) Eucalyptol prevents bleomycin-induced pulmonary fibrosis and M2 macrophage polarization. Eur J Pharmacol 931:175184. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175184","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"1610_CR53","doi-asserted-by":"publisher","first-page":"e1344","DOI":"10.1002\/ctm2.1344","volume":"13","author":"X Shao","year":"2023","unstructured":"Shao X, Xu P, Ji L, Wu B, Zhan Y, Zhuang X, Ou Y, Hua F, Sun L, Li F, Wang X, Chen H, Cheng Y (2023) Low-dose decitabine promotes M2 macrophage polarization in patients with primary immune thrombocytopenia via enhancing KLF4 binding to PPAR\u03b3 promoter. Clin Transl Med 13(7):e1344. https:\/\/doi.org\/10.1002\/ctm2.1344","journal-title":"Clin Transl Med"},{"issue":"9","key":"1610_CR54","doi-asserted-by":"publisher","first-page":"6425","DOI":"10.1002\/jcp.26429","volume":"233","author":"A Shapouri-Moghaddam","year":"2018","unstructured":"Shapouri-Moghaddam A, Mohammadian S, Vazini H, Taghadosi M, Esmaeili SA, Mardani F, Seifi B, Mohammadi A, Afshari JT, Sahebkar A (2018) Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol 233(9):6425\u20136440. https:\/\/doi.org\/10.1002\/jcp.26429","journal-title":"J Cell Physiol"},{"issue":"2","key":"1610_CR55","doi-asserted-by":"publisher","first-page":"C473","DOI":"10.1152\/ajpcell.00415.2023","volume":"326","author":"A Skeyni","year":"2024","unstructured":"Skeyni A, Pradignac A, Matz RL, Terrand J, Boucher P (2024) Cholesterol trafficking, lysosomal function, and atherosclerosis. Am J Physiol Cell Physiol 326(2):C473-c486. https:\/\/doi.org\/10.1152\/ajpcell.00415.2023","journal-title":"Am J Physiol Cell Physiol"},{"issue":"4","key":"1610_CR56","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/s2213-8587(19)30405-x","volume":"8","author":"TT Van Sloten","year":"2020","unstructured":"Van Sloten TT, Sedaghat S, Carnethon MR, Launer LJ, Stehouwer CDA (2020) Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression. Lancet Diabetes Endocrinol 8(4):325\u2013336. https:\/\/doi.org\/10.1016\/s2213-8587(19)30405-x","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1610_CR57","doi-asserted-by":"publisher","DOI":"10.1172\/jci154217","author":"B Wang","year":"2022","unstructured":"Wang B, Tang X, Yao L, Wang Y, Chen Z, Li M, Wu N, Wu D, Dai X, Jiang H, Ai D (2022) Disruption of USP9X in macrophages promotes foam cell formation and atherosclerosis. J Clin Invest. https:\/\/doi.org\/10.1172\/jci154217","journal-title":"J Clin Invest"},{"key":"1610_CR58","doi-asserted-by":"publisher","first-page":"107413","DOI":"10.1016\/j.phrs.2024.107413","volume":"209","author":"A Wang","year":"2024","unstructured":"Wang A, Guan B, Yu L, Liu Q, Hou Y, Li Z, Sun D, Xu H (2024) Palmatine protects against atherosclerosis by gut microbiota and phenylalanine metabolism. Pharmacol Res 209:107413. https:\/\/doi.org\/10.1016\/j.phrs.2024.107413","journal-title":"Pharmacol Res"},{"issue":"12","key":"1610_CR59","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1111\/dom.14174","volume":"22","author":"JM Wilson","year":"2020","unstructured":"Wilson JM, Nikooienejad A, Robins DA, Roell WC, Riesmeyer JS, Haupt A, Duffin KL, Taskinen MR, Ruotolo G (2020) The dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetes. Diabetes Obes Metab 22(12):2451\u20132459. https:\/\/doi.org\/10.1111\/dom.14174","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"1610_CR60","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1097\/mjt.0000000000001588","volume":"30","author":"E Wong","year":"2023","unstructured":"Wong E, Cope R, Dima L, Nguyen T (2023) Tirzepatide: a dual glucose-dependent insulinotropic polypeptide and glucagon-like Peptide-1 agonist for the management of Type 2 diabetes mellitus. Am J Ther 30(1):e26\u2013e35. https:\/\/doi.org\/10.1097\/mjt.0000000000001588","journal-title":"Am J Ther"},{"key":"1610_CR61","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-19-1592-5_7","author":"XH Yu","year":"2022","unstructured":"Yu XH, Tang CK (2022) ABCA1, ABCG1, and cholesterol homeostasis. Adv Exp Med Biol. https:\/\/doi.org\/10.1007\/978-981-19-1592-5_7","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"1610_CR62","doi-asserted-by":"publisher","first-page":"102000","DOI":"10.1016\/j.jbc.2022.102000","volume":"298","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Dong D, Xu X, He H, Zhu Y, Lei T, Ou H (2022) Oxidized high-density lipoprotein promotes CD36 palmitoylation and increases lipid uptake in macrophages. J Biol Chem 298(6):102000. https:\/\/doi.org\/10.1016\/j.jbc.2022.102000","journal-title":"J Biol Chem"},{"issue":"24","key":"1610_CR63","doi-asserted-by":"publisher","first-page":"4155","DOI":"10.1111\/jcmm.18000","volume":"27","author":"M Zhang","year":"2023","unstructured":"Zhang M, Hou L, Tang W, Lei W, Lin H, Wang Y, Long H, Lin S, Chen Z, Wang G, Zhao G (2023) Oridonin attenuates atherosclerosis by inhibiting foam macrophage formation and inflammation through FABP4\/PPAR\u03b3 signalling. J Cell Mol Med 27(24):4155\u20134170. https:\/\/doi.org\/10.1111\/jcmm.18000","journal-title":"J Cell Mol Med"},{"key":"1610_CR64","doi-asserted-by":"publisher","first-page":"116170","DOI":"10.1016\/j.bcp.2024.116170","volume":"223","author":"K Zhang","year":"2024","unstructured":"Zhang K, Li R, Matniyaz Y, Yu R, Pan J, Liu W, Wang D (2024) Liraglutide attenuates angiotensin II-induced aortic dissection and aortic aneurysm via inhibiting M1 macrophage polarization in APOE\/ mice. Biochem Pharmacol 223:116170. https:\/\/doi.org\/10.1016\/j.bcp.2024.116170","journal-title":"Biochem Pharmacol"},{"key":"1610_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2024.05.011","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Yan C, Dong Y, Zhao J, Yang X, Deng Y, Su L, Yin J, Zhang Y, Sun F, Feng Y (2025) ANGPTL3 accelerates atherosclerotic progression via direct regulation of M1 macrophage activation in plaque. J Adv Res. https:\/\/doi.org\/10.1016\/j.jare.2024.05.011","journal-title":"J Adv Res"},{"issue":"4","key":"1610_CR66","doi-asserted-by":"publisher","first-page":"H563","DOI":"10.1152\/ajpheart.00042.2013","volume":"305","author":"MS Zhou","year":"2013","unstructured":"Zhou MS, Chadipiralla K, Mendez AJ, Jaimes EA, Silverstein RL, Webster K, Raij L (2013) Nicotine potentiates proatherogenic effects of oxLDL by stimulating and upregulating macrophage CD36 signaling. Am J Physiol Heart Circ Physiol 305(4):H563\u2013H574. https:\/\/doi.org\/10.1152\/ajpheart.00042.2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1610_CR67","doi-asserted-by":"publisher","first-page":"108764","DOI":"10.1016\/j.clim.2021.108764","volume":"229","author":"H Zhuang","year":"2021","unstructured":"Zhuang H, Han S, Lu L, Reeves WH (2021) Myxomavirus serpin alters macrophage function and prevents diffuse alveolar hemorrhage in pristane-induced lupus. Clin Immunol 229:108764. https:\/\/doi.org\/10.1016\/j.clim.2021.108764","journal-title":"Clin Immunol"}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-026-01610-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12272-026-01610-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-026-01610-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:13:05Z","timestamp":1777860785000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12272-026-01610-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,29]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1610"],"URL":"https:\/\/doi.org\/10.1007\/s12272-026-01610-3","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,29]]},"assertion":[{"value":"7 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that the work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}